BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20060024)

  • 1. Development and optimization of a doxorubicin loaded poly(lactic acid) contrast agent for ultrasound directed drug delivery.
    Eisenbrey JR; Burstein OM; Kambhampati R; Forsberg F; Liu JB; Wheatley MA
    J Control Release; 2010 Apr; 143(1):38-44. PubMed ID: 20060024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound triggered cell death in vitro with doxorubicin loaded poly lactic-acid contrast agents.
    Eisenbrey JR; Huang P; Hsu J; Wheatley MA
    Ultrasonics; 2009 Dec; 49(8):628-33. PubMed ID: 19394992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of encapsulated Doxorubicin by ultrasound-mediated size reduction of drug-loaded polymer contrast agents.
    Eisenbrey JR; Soulen MC; Wheatley MA
    IEEE Trans Biomed Eng; 2010 Jan; 57(1):24-8. PubMed ID: 19709952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma sterilization of poly lactic acid ultrasound contrast agents: surface modification and implications for drug delivery.
    Eisenbrey JR; Hsu J; Wheatley MA
    Ultrasound Med Biol; 2009 Nov; 35(11):1854-62. PubMed ID: 19766380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: Part I--Formulation development and in-vitro characterization.
    Tinkov S; Winter G; Coester C; Bekeredjian R
    J Control Release; 2010 Apr; 143(1):143-50. PubMed ID: 20060861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
    Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
    Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate-targeting magnetic core-shell nanocarriers for selective drug release and imaging.
    Wang H; Wang S; Liao Z; Zhao P; Su W; Niu R; Chang J
    Int J Pharm; 2012 Jul; 430(1-2):342-9. PubMed ID: 22525087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and optimization of doxorubicin loaded poly(lactic-co-glycolic acid) nanobubbles for drug delivery into HeLa cells.
    Deng L; Li L; Yang H; Li L; Zhao F; Wu C; Liu Y
    J Nanosci Nanotechnol; 2014 Apr; 14(4):2947-54. PubMed ID: 24734715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Delivery from a Multi-faceted Ultrasound Contrast Agent: Influence of Shell Composition.
    Jablonowski LJ; Teraphongphom NT; Wheatley MA
    Mol Pharm; 2017 Oct; 14(10):3448-3456. PubMed ID: 28814080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles.
    Liu M; Li H; Luo G; Liu Q; Wang Y
    Arch Pharm Res; 2008 Apr; 31(4):547-54. PubMed ID: 18449515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery.
    Cochran MC; Eisenbrey J; Ouma RO; Soulen M; Wheatley MA
    Int J Pharm; 2011 Jul; 414(1-2):161-70. PubMed ID: 21609756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
    Liu SQ; Tong YW; Yang YY
    Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.
    Liu Y; Feng L; Liu T; Zhang L; Yao Y; Yu D; Wang L; Zhang N
    Nanoscale; 2014 Mar; 6(6):3231-42. PubMed ID: 24500240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability.
    Benival DM; Devarajan PV
    Int J Pharm; 2012 Feb; 423(2):554-61. PubMed ID: 22155412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal delivery of zidovudine by PLA and PLA-PEG blend nanoparticles.
    Mainardes RM; Khalil NM; GremiĆ£o MP
    Int J Pharm; 2010 Aug; 395(1-2):266-71. PubMed ID: 20580792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of biodegradable films containing the potent osteogenic compound BFB0261 for localized delivery.
    Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
    Int J Pharm; 2011 Feb; 404(1-2):10-8. PubMed ID: 21047548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced anti-topoisomerase II activity by mucoadhesive 4-CBS-chitosan/poly (lactic acid) nanoparticles.
    Songsurang K; Suvannasara P; Phurat C; Puthong S; Siraleartmukul K; Muangsin N
    Carbohydr Polym; 2013 Nov; 98(2):1335-42. PubMed ID: 24053811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of anticancer drug using pH-sensitive micelles from triblock copolymer MPEG-b-PBAE-b-PLA.
    Yang C; Xue Z; Liu Y; Xiao J; Chen J; Zhang L; Guo J; Lin W
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():254-262. PubMed ID: 29519437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction-responsive shell-sheddable biodegradable micelles for intracellular doxorubicin delivery.
    Sun H; Guo B; Cheng R; Meng F; Liu H; Zhong Z
    J Control Release; 2011 Nov; 152 Suppl 1():e84-5. PubMed ID: 22195945
    [No Abstract]   [Full Text] [Related]  

  • 20. Spatiotemporal drug delivery using laser-generated-focused ultrasound system.
    Di J; Kim J; Hu Q; Jiang X; Gu Z
    J Control Release; 2015 Dec; 220(Pt B):592-9. PubMed ID: 26299506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.